A detailed history of Cubist Systematic Strategies, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 666,578 shares of ACAD stock, worth $9.86 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
666,578
Previous 666,578 -0.0%
Holding current value
$9.86 Million
Previous $10.8 Million -0.0%
% of portfolio
0.08%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$14.62 - $18.42 $3.14 Million - $3.96 Million
215,060 Added 47.63%
666,578 $10.8 Million
Q1 2024

May 15, 2024

BUY
$17.79 - $30.86 $1.18 Million - $2.05 Million
66,273 Added 17.2%
451,518 $8.35 Million
Q4 2023

Feb 14, 2024

BUY
$20.78 - $31.77 $8.01 Million - $12.2 Million
385,245 New
385,245 $12.1 Million
Q2 2023

Aug 14, 2023

SELL
$17.8 - $25.65 $2.67 Million - $3.85 Million
-150,109 Reduced 56.82%
114,062 $2.73 Million
Q1 2023

May 15, 2023

BUY
$16.32 - $20.92 $4.13 Million - $5.3 Million
253,282 Added 2326.04%
264,171 $4.97 Million
Q4 2022

Feb 14, 2023

SELL
$14.2 - $18.63 $1.31 Million - $1.71 Million
-91,936 Reduced 89.41%
10,889 $173,000
Q3 2022

Nov 14, 2022

BUY
$14.11 - $18.27 $1.06 Million - $1.37 Million
74,952 Added 268.91%
102,825 $1.68 Million
Q2 2022

Aug 15, 2022

SELL
$13.01 - $27.22 $1.42 Million - $2.97 Million
-109,010 Reduced 79.64%
27,873 $393,000
Q1 2022

May 16, 2022

BUY
$20.94 - $27.5 $1.93 Million - $2.53 Million
92,063 Added 205.41%
136,883 $3.32 Million
Q4 2021

Feb 14, 2022

SELL
$16.79 - $27.09 $1.48 Million - $2.39 Million
-88,106 Reduced 66.28%
44,820 $1.05 Million
Q3 2021

Nov 15, 2021

BUY
$15.78 - $24.77 $870,424 - $1.37 Million
55,160 Added 70.93%
132,926 $2.21 Million
Q2 2021

Aug 16, 2021

BUY
$19.4 - $27.42 $643,129 - $909,000
33,151 Added 74.3%
77,766 $1.9 Million
Q1 2021

May 17, 2021

SELL
$25.02 - $54.99 $1.4 Million - $3.08 Million
-55,993 Reduced 55.65%
44,615 $1.15 Million
Q4 2020

Feb 16, 2021

BUY
$41.04 - $56.79 $3.2 Million - $4.42 Million
77,896 Added 342.97%
100,608 $5.38 Million
Q3 2020

Nov 16, 2020

SELL
$36.42 - $57.0 $8.83 Million - $13.8 Million
-242,534 Reduced 91.44%
22,712 $937,000
Q2 2020

Aug 14, 2020

BUY
$39.26 - $52.73 $10.4 Million - $14 Million
265,246 New
265,246 $12.9 Million
Q1 2020

May 15, 2020

SELL
$31.65 - $46.87 $1.12 Million - $1.66 Million
-35,348 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$36.21 - $51.4 $2.24 Million - $3.18 Million
-61,828 Reduced 63.62%
35,348 $1.51 Million
Q3 2019

Nov 14, 2019

BUY
$22.22 - $44.01 $2 Million - $3.96 Million
89,913 Added 1237.96%
97,176 $3.5 Million
Q2 2019

Aug 14, 2019

SELL
$23.32 - $28.12 $2.61 Million - $3.14 Million
-111,762 Reduced 93.9%
7,263 $194,000
Q1 2019

May 15, 2019

BUY
$16.17 - $27.38 $1.84 Million - $3.11 Million
113,647 Added 2113.18%
119,025 $3.2 Million
Q4 2018

Feb 14, 2019

SELL
$14.32 - $22.92 $323,145 - $517,212
-22,566 Reduced 80.75%
5,378 $87,000
Q3 2018

Nov 14, 2018

SELL
$13.03 - $21.81 $22,294 - $37,316
-1,711 Reduced 5.77%
27,944 $580,000
Q2 2018

Aug 14, 2018

BUY
$15.07 - $22.34 $287,731 - $426,537
19,093 Added 180.77%
29,655 $453,000
Q1 2018

May 15, 2018

BUY
$22.47 - $32.33 $121,248 - $174,452
5,396 Added 104.45%
10,562 $237,000
Q4 2017

Feb 14, 2018

SELL
$26.84 - $39.14 $118,418 - $172,685
-4,412 Reduced 46.06%
5,166 $156,000
Q3 2017

Nov 14, 2017

BUY
$29.49 - $38.37 $282,455 - $367,507
9,578
9,578 $361,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.